Abiopharma

🔍 Gibber David B (Executive)

Company: Sinclair, Inc. (SBGI)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Sold 28,828 shares of Class A Common Stock at $13.7414 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 184,244.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 418 shares of Class A Common Stock at $13.82 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 184,244.00 | transaction_form_type: 4 | Footnotes: F5, F3
• Sold 5,799 shares of Class A Common Stock at $13.76 per share (Direct)
  Date: 2026-08-10 | Code: I | equity_swap_involved: 0 | shares_owned_after: 184,244.00 | transaction_form_type: 4 | Footnotes: F6, F3

Footnotes:

• F1: Class A Common Stock issued as Restricted Stock.
• F2: The purchase price is a weighted average for the purchase reported. The range of prices for this purchase was $13.67-$13.84. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
• F3: Common Stock issued as Restricted Stock.
• F4: After giving effect to all of the transactions reported on this Form 4, Reporting Person also owns 0 shares of Class A Common Stock held in a 401(k) unitized stock fund, 0 shares of Class A Common Stock held in an Employee Stock Purchase Plan, and 307,707 shares of Class A Common Stock issued as Stock Appreciation Rights.
• F5: Class A Common Stock held in an Employee Stock Purchase Plan.
• F6: Class A Common Stock held in a 401(k) unitized stock fund.